CG Oncology, Inc. held its 2026 Annual Meeting of Stockholders on June 4, 2026, where stockholders elected Christina Rossi and Victor Tong, Jr. as Class II directors. The meeting also included the ratification of Ernst & Young LLP as the independent registered public accounting firm and advisory votes on executive compensation and the preference for the annual frequency of advisory votes on executive compensation.